GlassScriptPhysician profile
Tiffany A Long
NPI 1033562442
$943.23
in general payments reported to CMS, 2019-2025
16 companies · $33.56 in 2025
The $33.56 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $359 · 2023: $91.78 · 2025: $33.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.62 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $127.82 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $113.38 | 2021 | |
| Nevro Corp. | $88.74 | 2022 | |
| Boston Scientific Corporation | $68.31 | 2021-2025 | General - Pain Management |
| Lilly USA, LLC | $52.77 | 2021 | |
| Biodelivery Sciences International, INC. | $41.13 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $36.69 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.01 | 2021-2022 | |
| Radius Health, INC. | $20.37 | 2022 | |
| Amgen INC. | $18.81 | 2021 | |
| Medtronic, INC. | $17.51 | 2022 | |
| Merz Pharmaceuticals, LLC | $16.39 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.31 | 2022 | |
| Nalu Medical, INC. | $14.93 | 2023 | Nalu Neurostimulation System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.